Recombinant Mouse Eotaxin-2
- -
- -
BackgroundEotaxin-2 is a CC chemokine that is a specific agonist for the chemokine receptor CCR3. It is produced by activated monocytes and T lymphocytes. Eotaxin-2 induces chemotaxis of eosinophils as well as basophils and the release of histamine and leukotriene C4 from basophils. Eotaxin-2 has the same efficacy as eotaxin, but is somewhat less potent. 1 Additionally, Eotaxin-2 inhibits the proliferation of multipotential hematopoietic progenitor cells. Protein DetailsPurity >95% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.01EU/µg as determined by the LAL method Biological Activity The biological activity of Mouse Eotaxin-2 was determined by its ability to induce chemotaxis of mouse BaF/3 cells transfected with mCCR3. The expected ED<sub>50</sub>= 150 - 600 ng/ml. Protein Accession No. Amino Acid Sequence idsvtip sscctsfisk kipenrvvsy qlangsicpk agvifitkkg hkictdpkll wvqrhiqkld akknqpskga kavrtkfavq rrrgnstev
N-terminal Sequence Analysis Ile24 State of Matter Lyophilized Predicted Molecular Mass The predicted molecular weight of Recombinant Mouse Eotaxin-2 is Mr 10.6 kDa. Predicted Molecular Mass 10.6 Formulation This recombinant protein was lyophilized from a 0.2 μm filtered solution in 35% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA). Storage and Stability This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions. Country of Origin USA Shipping Next Day Ambient NCBI Gene Bank References & Citations1. Baggiolini, M. et al. (1997) J. Exp. Med. 185: 2171 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.